Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles C Wykoff

Showing results (1-10 of 355) with videos related to

Pageof 36
Sort By:
Ophthalmology. Retina|November 9, 2019
Thresholds for Initiating Treatment of Eyes with Diabetic Macular Edema and Good Vision: Consideration of DRCR.Net Protocol V ResultsCharles C Wykoff
Current Opinion in Ophthalmology|April 5, 2017
Impact of intravitreal pharmacotherapies including antivascular endothelial growth factor and corticosteroid agents on diabetic retinopathyCharles C Wykoff
Journal of Cataract and Refractive Surgery|June 13, 2006
Myopic laser in situ keratomileusis in eyes with thick corneasCharles C Wykoff, Roberto Pineda
Lancet (London, England)|November 17, 2017
Intravitreal aflibercept for proliferative diabetic retinopathyDavid M Brown, Charles C Wykoff
International Journal of Retina and Vitreous|June 5, 2019
Looking ahead in retinal disease management: <i>highlights of the 2019 angiogenesis, exudation and degeneration symposium</i>Carmen A Puliafito, Charles C Wykoff
International Journal of Retina and Vitreous|June 2, 2020
New Frontiers in Retina: highlights of the 2020 angiogenesis, exudation and degeneration symposiumCarmen A Puliafito, Charles C Wykoff
Ophthalmic Surgery, Lasers & Imaging Retina|April 12, 2016
DRCR Protocol-T: Reconciling 1- and 2-Year Data for Managing Diabetic Macular EdemaCharles C Wykoff, Seenu M Hariprasad
Ophthalmic Surgery, Lasers & Imaging Retina|April 4, 2015
Comparing aflibercept, bevacizumab, and ranibizumab for DME: analysis of DRCR Protocol TCharles C Wykoff, Seenu M Hariprasad
Retina (Philadelphia, Pa.)|August 13, 2011
Endophthalmitis after intravitreal injection: prevention and managementCharles C Wykoff, Harry W Flynn
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 24, 2021
Investigational Agents in Development for the Treatment of Geographic Atrophy Secondary to Age-Related Macular DegenerationHannah J Yu, Charles C Wykoff
Pageof 36

Showing results (1-10 of 355) with videos related to

Sort By:
Pageof 36
Ophthalmology. Retina|November 9, 2019
Thresholds for Initiating Treatment of Eyes with Diabetic Macular Edema and Good Vision: Consideration of DRCR.Net Protocol V ResultsCharles C Wykoff
Current Opinion in Ophthalmology|April 5, 2017
Impact of intravitreal pharmacotherapies including antivascular endothelial growth factor and corticosteroid agents on diabetic retinopathyCharles C Wykoff
Journal of Cataract and Refractive Surgery|June 13, 2006
Myopic laser in situ keratomileusis in eyes with thick corneasCharles C Wykoff, Roberto Pineda
Lancet (London, England)|November 17, 2017
Intravitreal aflibercept for proliferative diabetic retinopathyDavid M Brown, Charles C Wykoff
International Journal of Retina and Vitreous|June 5, 2019
Looking ahead in retinal disease management: <i>highlights of the 2019 angiogenesis, exudation and degeneration symposium</i>Carmen A Puliafito, Charles C Wykoff
International Journal of Retina and Vitreous|June 2, 2020
New Frontiers in Retina: highlights of the 2020 angiogenesis, exudation and degeneration symposiumCarmen A Puliafito, Charles C Wykoff
Ophthalmic Surgery, Lasers & Imaging Retina|April 12, 2016
DRCR Protocol-T: Reconciling 1- and 2-Year Data for Managing Diabetic Macular EdemaCharles C Wykoff, Seenu M Hariprasad
Ophthalmic Surgery, Lasers & Imaging Retina|April 4, 2015
Comparing aflibercept, bevacizumab, and ranibizumab for DME: analysis of DRCR Protocol TCharles C Wykoff, Seenu M Hariprasad
Retina (Philadelphia, Pa.)|August 13, 2011
Endophthalmitis after intravitreal injection: prevention and managementCharles C Wykoff, Harry W Flynn
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 24, 2021
Investigational Agents in Development for the Treatment of Geographic Atrophy Secondary to Age-Related Macular DegenerationHannah J Yu, Charles C Wykoff
Pageof 36